CoChat

Neuroimaging in dementia.

Open access

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Abstract

Dementia is a common illness with an incidence that is rising as the aged population increases. There are a number of neurodegenerative diseases that cause dementia, including Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia, which is subdivided into the behavioral variant, the semantic variant, and nonfluent variant. Numerous other neurodegenerative illnesses have an associated dementia, including corticobasal degeneration, Creutzfeldt-Jakob disease, Huntington's disease, progressive supranuclear palsy, multiple system atrophy, Parkinson's disease dementia, and amyotrophic lateral sclerosis. Vascular dementia and AIDS dementia are secondary dementias. Diagnostic criteria have relied on a constellation of symptoms, but the definite diagnosis remains a pathologic one. As treatments become available and target specific molecular abnormalities, differentiating amongst the various primary dementias early on becomes essential. The role of imaging in dementia has traditionally been directed at ruling out treatable and reversible etiologies and not to use imaging to better understand the pathophysiology of the different dementias. Different brain imaging techniques allow the examination of the structure, biochemistry, metabolic state, and functional capacity of the brain. All of the major neurodegenerative disorders have relatively specific imaging findings that can be identified. New imaging techniques carry the hope of revolutionizing the diagnosis of neurodegenerative disease so as to obtain a complete molecular, structural, and metabolic characterization, which could be used to improve diagnosis and to stage each patient and follow disease progression and response to treatment. Structural and functional imaging modalities contribute to the diagnosis and understanding of the different dementias.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13311-010-0012-2

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Coronal magnetic resonance imaging through the brain of patient with Alzheimer’s disease (AD). Notice the enlarged temporal horns due to hippocampal atrophy. Voxel-based morphometry analysis showing volume loss in AD compared with the controls in the hippocampus, entorhinal cortex, parietal and lateral posterior superior temporal regions, and medial posterior portion of the cingulate gyrus. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 1. Coronal magnetic resonance imaging through the brain of patient with Alzheimer’s disease (AD). Notice the enlarged temporal horns due to hippocampal atrophy. Voxel-based morphometry analysis showing volume loss in AD compared with the controls in the hippocampus, entorhinal cortex, parietal and lateral posterior superior temporal regions, and medial posterior portion of the cingulate gyrus. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 2. Top row: Sagittal view of a patient with the behavioral variant of frontotemporal dementia (bvFTD); note the anterior atrophy with relative sparing of the parietal and occipital regions. The anterior corpus callosum is also thinned compared to posterior. Coronal view of patient with semantic dementia showing significant left temporal atrophy. Coronal view of patient with nonfluent variant of FTD showing significant left insular atrophy. Bottom row: VBM study showing that in patients with bvFTD, frontal lobe volumes are reduced compared with age-matched controls. There is volume loss in the ventromedial frontal cortex, the posterior orbital frontal regions, the insula, and the anterior cingulate cortex. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 2. Top row: Sagittal view of a patient with the behavioral variant of frontotemporal dementia (bvFTD); note the anterior atrophy with relative sparing of the parietal and occipital regions. The anterior corpus callosum is also thinned compared to posterior. Coronal view of patient with semantic dementia showing significant left temporal atrophy. Coronal view of patient with nonfluent variant of FTD showing significant left insular atrophy. Bottom row: VBM study showing that in patients with bvFTD, frontal lobe volumes are reduced compared with age-matched controls. There is volume loss in the ventromedial frontal cortex, the posterior orbital frontal regions, the insula, and the anterior cingulate cortex. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 3. Cross-section through the hippocampus at the level of the red nucleus in a normal control, obtained using a 7T gradient-recalled echo sequence. DG = Dentate gyrus, CA1–3 = cornus ammonis subfields 1–3, sp = stratum pyramidale, srlm = stratum radiatum/stratum lacunosum-moleculare, EC = entorhinal cortex. Scale bar 1 mm. Image has been reproduced courtesy of Dr. Geoffrey A. Kerchner. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 3. Cross-section through the hippocampus at the level of the red nucleus in a normal control, obtained using a 7T gradient-recalled echo sequence. DG = Dentate gyrus, CA1–3 = cornus ammonis subfields 1–3, sp = stratum pyramidale, srlm = stratum radiatum/stratum lacunosum-moleculare, EC = entorhinal cortex. Scale bar 1 mm. Image has been reproduced courtesy of Dr. Geoffrey A. Kerchner. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 4. (A) Axial section through fluid-attentuated inversion recovery image from a patient with vascular dementia, showing multiple patchy areas of high signal in periventricular white matter. (B) Coronal gradient echo MR image showing multiple microhemorrhages. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 4. (A) Axial section through fluid-attentuated inversion recovery image from a patient with vascular dementia, showing multiple patchy areas of high signal in periventricular white matter. (B) Coronal gradient echo MR image showing multiple microhemorrhages. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 5. Axial diffusion-weighted imaging showing cortical ribboning, left more than right, in a patient with Creutzfeldt–Jakob disease. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 5. Axial diffusion-weighted imaging showing cortical ribboning, left more than right, in a patient with Creutzfeldt–Jakob disease. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 6. Diffusion tensor imaging-derived tracts in normal controls. Unc = Uncinate, SLF = superior longitudinal fasciculus, ILF = inferior longitudinal fasciculus. Image has been reproduced courtesy of Dr. Sebastiano Galantucci. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 6. Diffusion tensor imaging-derived tracts in normal controls. Unc = Uncinate, SLF = superior longitudinal fasciculus, ILF = inferior longitudinal fasciculus. Image has been reproduced courtesy of Dr. Sebastiano Galantucci. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 7. [18F]Fluorodeoxyglucose–positron emission tomography (PET) scan of AD and FTD patients. Note reduced glucose metabolism in the superior/posterior temporal and parietal regions of the AD scan. In comparison, the FTD scan shows hypometabolism in the frontal and anterior temporal regions, with relative sparing of the posterior brain regions. Image has been reproduced courtesy of Dr. Gil Rabinovici. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 7. [18F]Fluorodeoxyglucose–positron emission tomography (PET) scan of AD and FTD patients. Note reduced glucose metabolism in the superior/posterior temporal and parietal regions of the AD scan. In comparison, the FTD scan shows hypometabolism in the frontal and anterior temporal regions, with relative sparing of the posterior brain regions. Image has been reproduced courtesy of Dr. Gil Rabinovici. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central
FIG. 8. Results of a Pittsburgh Compound B (PiB) PET scan. PiB reveals amyloid in the brain. Warmer colors (e.g., red) indicate greater concentrations of amyloid deposition, and blue indicates the absence of amyloid on a PiB PET scan. Image has been reproduced courtesy of Dr. Gil Rabinovici. (High resolution version of this image is available in the electronic supplementary material.)
FIG. 8. Results of a Pittsburgh Compound B (PiB) PET scan. PiB reveals amyloid in the brain. Warmer colors (e.g., red) indicate greater concentrations of amyloid deposition, and blue indicates the absence of amyloid on a PiB PET scan. Image has been reproduced courtesy of Dr. Gil Rabinovici. (High resolution version of this image is available in the electronic supplementary material.)CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Cited by

See all 142

Metadata

Authors
Tartaglia, M. C., Rosen, H. J., & Miller, B. L.
Affiliations
University of California, San Francisco (US)
Corresponding author
Tartaglia, Maria Carmela
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2011-01
Volume
8
Issue
1
Pages
82-92
ISSN
1878-7479 (ISSN-L)
OpenAlex
W2019373590
Cited by
124
References
88
Citations by year
2026: 8 · 2025: 8 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 11 · 2017: 10 · 2016: 5 · 2015: 10 · 2014: 8 · 2013: 12 · 2012: 11
FWCI
1.76
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurotherapeutics (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
Funders
National Institute on Aging (P01AG019724)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
dementia, neuroimaging, neurodegenerative diseases, Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, Creutzfeldt-Jakob disease, Huntington's disease, progressive supranuclear palsy, multiple system atrophy, Parkinson's disease dementia, amyotrophic lateral sclerosis, vascular dementia, HIV-associated dementia, differential diagnosis, disease staging, disease progression monitoring, structural imaging, functional imaging
MeSH terms
Alzheimer Disease, Dementia, Humans, Magnetic Resonance Imaging, Positron-Emission Tomography, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroimaging in dementia. https://app.cochat.ai/papers/10.1007/s13311-010-0012-2
The paper
Tartaglia, M. C., Rosen, H. J., & Miller, B. L. (2011). Neuroimaging in dementia. Neurotherapeutics. https://doi.org/10.1007/s13311-010-0012-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.